Skip to content
PoliticalRepoPoliticalRepo

United States · Bill · HR

H.R. 4489 (111th)

FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act

openUnited States· United States Congress· EN

Introduced

21 January 2010

Last action

24 March 2010 · Committee

Status

Forwarded by Subcommittee to Full Committee (Amended) by Voice Vote .

Sponsors

Rep. Lynch, Stephen F. [D-MA-8], Rep. Connolly, Gerald E. [D-VA-11], Rep. Cummings, Elijah E. [D-MD-7], Rep. Doggett, Lloyd [D-TX-37], Rep. Clay, Wm. Lacy [D-MO-1], Del. Norton, Eleanor Holmes [D-DC-At Large], Rep. Kucinich, Dennis J. [D-OH-10], Rep. Weiner, Anthony D. [D-NY-9], Rep. Hodes, Paul W. [D-NH-2], Rep. Driehaus, Steve [D-OH-1], Rep. Chu, Judy [D-CA-28], Rep. Delahunt, William D. [D-MA-10], Rep. Moran, James P. [D-VA-8], Rep. Visclosky, Peter J. [D-IN-1], Rep. Filner, Bob [D-CA-51], Rep. Sánchez, Linda T. [D-CA-38], Rep. Marshall, Jim [D-GA-8]

Subjects

Discovery layer

Source updated

14 August 2025

Summary

FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act - Prohibits the Office of Personnel Management (OPM) from entering a contract or approving a health benefits plan with a carrier that is a party to a pharmacy benefit manager (PBM) carrier arrangement to provide or administer prescription drug coverage under the Federal Employees Health Benefits Program (FEHBP) unless the PBM and the carrier comply with requirements of this Act. Directs OPM to terminate a contract or discontinue a plan that fails to comply. Prohibits: (1) a pharmaceutical drug manufacturer or retail pharmacy from having a controlling interest in the PBM; or (2) the PBM from having a controlling interest in a retail pharmacy. Requires each carrier to certify PBM compliance annually. Prohibits OPM from permitting a carrier that has a controlling interest in a PBM to earn a profit from such interest with respect to an FEHBP contract. Sets forth requirements of PBM arrangements under the FEHBP, including regarding: (1) drug substitution restrictions; (2) PBM reimbursement of carriers; (3) sale by a PBM of utilization and claims data; (4) drug pricing and the basis for reimbursement; (5) provisions of an explanation of benefits to enrollees; (6) nondiscriminatory contracts regarding required participation; (7) OPM access to PBM contract information; (8) civil monetary penalties for making false statements or claims to the government; and (9) reports from drug manufacturers on average manufacturer prices for drugs each quarter.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

  1. 21 January 2010

    Introduced

    Sponsor introductory remarks on measure. (CR E70-71)

    Source: IntroReferral

  2. 21 January 2010

    Introduced

    Introduced in House

    Source: IntroReferral

  3. 21 January 2010

    Introduced

    Introduced in House

    Source: IntroReferral

  4. 21 January 2010

    Introduced

    Referred to the House Committee on Oversight and Government Reform.

    Source: IntroReferral

  5. 12 February 2010

    Referred

    Referred to the Subcommittee on Federal Workforce, Post Office, and the District of Columbia.

    Source: Committee

  6. 23 February 2010

    Committee

    Subcommittee Hearings Held.

    Source: Committee

  7. 24 March 2010

    Committee

    Subcommittee Consideration and Mark-up Session Held.

    Source: Committee

  8. 24 March 2010

    Committee

    Forwarded by Subcommittee to Full Committee (Amended) by Voice Vote .

    Source: Committee

Votes

No vote records are attached yet.

Versions

Documents

3 official files

Introduced in House (text)

View fileDownload file

This file cannot be previewed here. Use View or Download.

Leesvertaling

Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Introduced in House (text)

    Introduced in House · EN · 21 January 2010

    ViewDownloadOpen at official source

  • Introduced in House (PDF)

    Introduced in House · EN · 21 January 2010

    ViewDownloadOpen at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Introduced in House

    summary · EN · 21 January 2010

    Open at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

Sponsors

Related records

No cross-record relationships stored yet.

Sources

PoliticalRepo is an index and interpretation layer, not the authoritative legal source.